RCUS — Arcus Biosciences, Inc. stock price, charts and financials

QT64Arcus Biosciences, Inc.

Arcus Biosciences, Inc. (NYSE: RCUS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
28.80
+1.18+4.27%
OverviewShort InterestFilings
RCUSQT64Arcus Biosciences, Inc.·NYSE
28.80+4.27%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 13, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
May 12, 20264Statement of changes in beneficial ownership
May 12, 20264Statement of changes in beneficial ownership
May 05, 202610-QQuarterly report
May 05, 20268-KCurrent report
Apr 21, 2026ARSAnnual report to shareholders
Apr 21, 2026DEFA14AAdditional proxy soliciting materials
Apr 21, 2026DEF 14ADefinitive proxy statement
Apr 20, 20268-KCurrent report
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 23, 20268-KCurrent report
Feb 25, 2026S-8Registration of employee benefit securities
Feb 25, 20268-KCurrent report
Feb 25, 2026S-3ASRS-3ASR
#1 / 25 of 318
Page
▼
/ 13